Tectonic Therapeutic (TECX) Non Operating Income (2017 - 2026)
Tectonic Therapeutic (TECX) posted quarterly Non Operating Income of $2.1 million for Q1 2026, down 13.88% year-over-year from $2.4 million in Q1 2025, and down 19.03% quarter-over-quarter from $2.5 million in Q4 2025.
Tectonic Therapeutic (TECX) Non Operating Income (2017 - 2026) Analysis & Trends
Tectonic Therapeutic (TECX) has reported Non Operating Income for 10 consecutive years, with $2.1 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Non Operating Income fell 13.88% year-over-year to $2.1 million; the TTM figure through Mar 2026 stood at $10.8 million (up 130.41% YoY), while the FY2025 annual figure was $11.1 million, up 33581.82% from the prior year.
- Non Operating Income fell to $2.1 million in Q1 2026 per TECX's latest filing, from $2.5 million in the prior quarter.
- Across five years, Non Operating Income topped out at $3.3 million in Q2 2025 and bottomed at -$2.3 million in Q1 2024.
- Historically, Non Operating Income has averaged $868117.6 across 5 years, with a median of $263000.0 in 2023.
- Annual changes were most pronounced in 2022 — Non Operating Income sank 2666.67% — and 2024, when it jumped 3100.0%.
- Tectonic Therapeutic's Non Operating Income stood at $223000.0 in 2022, then surged by 574.89% to $1.5 million in 2023, then increased by 7.51% to $1.6 million in 2024, then soared by 57.23% to $2.5 million in 2025, then fell by 19.03% to $2.1 million in 2026.
- Business Quant data shows TECX's Non Operating Income at $2.1 million in Q1 2026, $2.5 million in Q4 2025, and $2.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 234.30 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -139.24 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 12.40 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | -51.63 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -53.64 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Tectonic Therapeutic | 671.50 Mn | 671.50 Mn | - | 2.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.01 Mn |
| Mar 31, 2026 | 2.06 Mn |
| Dec 31, 2025 | 2.54 Mn |
| Sep 30, 2025 | 2.86 Mn |
| Jun 30, 2025 | 3.32 Mn |
| Mar 31, 2025 | 2.39 Mn |
| Dec 31, 2024 | 1.62 Mn |
| Sep 30, 2024 | 1.92 Mn |
| Jun 30, 2024 | -1.25 Mn |
| Mar 31, 2024 | -2.25 Mn |
| Dec 31, 2023 | 1.51 Mn |
| Sep 30, 2023 | 60,000.00 |
| Jun 30, 2023 | 176,000.00 |
| Mar 31, 2023 | 263,000.00 |
| Dec 31, 2022 | 223,000.00 |
| Sep 30, 2022 | 16,000.00 |
| Jun 30, 2022 | -280,000.00 |
| Mar 31, 2022 | -415,000.00 |
| Dec 31, 2021 | -265,000.00 |
| Sep 30, 2021 | 7,000.00 |